Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
IONS
Stock Latest News
The Fly
Ionis announces Geary to retire as Chief Development Officer
9d ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Announces Leadership Transition
9d ago
8K
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $48 from $45 at JPMorgan
9d ago
IONS
Premium
The Fly
Ionis Pharmaceuticals doses first patient in REVEAL study
10d ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Holds Annual Stockholders Meeting
11d ago
8K
IONS
Premium
Ratings
Ionis Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Trial Results and Future Prospects
1M ago
IONS
Premium
Ratings
Cautious Optimism for Ionis Pharmaceuticals Amid Promising Olezarsen Data and Awaited CORE/CORE2 Insights
1M ago
IONS
Premium
Ratings
Promising Phase 3 Results and Future Prospects of Tryngolza Drive Buy Rating for Ionis Pharmaceuticals
1M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals’ Promising Future: Buy Rating Backed by Positive Phase 3 Study Results and Upcoming Milestones
1M ago
IONS
Premium
Ratings
Promising Clinical Trial Results and Market Potential Justify Buy Rating for Ionis Pharmaceuticals
1M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Hold Rating Amid Promising Yet Preliminary Clinical Trial Results
1M ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Announces Positive Essence Study Results
1M ago
8K
IONS
Premium
The Fly
Ionis Pharmaceuticals announces topline results from Essence study of olezarsen
1M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
2M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target raised to $50 from $45 at H.C. Wainwright
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Buy Rating Backed by Robust Drug Performance and Strategic Market Expansion
2M ago
IONS
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $64 from $65 at Guggenheim
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Q1 Performance and Future Growth Potential Drive Buy Rating
2M ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong Q1 2025 Results
2M ago
IONS
Premium
Company Announcements
Ionis Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Strategic Partnerships Justify Buy Rating Despite Adjusted Price Target
2M ago
IONS
Premium
Ratings
Ionis Pharmaceuticals: Strong Performance and Promising Pipeline Justify Buy Rating
2M ago
IONS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
